相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Factors mediating cancer risk in systemic lupus erythematosus
Dylan Hardenbergh et al.
LUPUS (2022)
Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis
Ann E. Clarke et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors
Hjalmar Wadstrom et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Autoantibodies in Early Detection of Breast Cancer
Femina Rauf et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Anti-nuclear antibodies in patients with breast cancer
R. Nisihara et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Autoantibodies as Potential Biomarkers in Breast Cancer
Jingyi Qiu et al.
BIOSENSORS-BASEL (2018)
The Clinical Relevance of Anti-DFS70 Autoantibodies
Karsten Conrad et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)
The giant protein titin regulates the length of the striated muscle thick filament
Paola Tonino et al.
NATURE COMMUNICATIONS (2017)
Sequence-structure relationships, expression profiles, and disease-associated mutations in the paralogs of phosphoglucomutase 1
Andrew G. Muenks et al.
PLOS ONE (2017)
The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions
Irena Meistere et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Functional germline variants in driver genes of breast cancer
Stella Goehler et al.
CANCER CAUSES & CONTROL (2017)
The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding
Robert L. Ochs et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2016)
Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromes
Benjamin Berger et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Titin antibodies in seronegative myasthenia gravis - A new role for an old antigen
C. Stergiou et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Cancer-Induced Autoimmunity in the Rheumatic Diseases
Ami A. Shah et al.
ARTHRITIS & RHEUMATOLOGY (2015)
DFS70/LEDGFp75: an enigmatic autoantigen at the interface between autoimmunity, AIDS and cancer
Anamika Basu et al.
FRONTIERS IN IMMUNOLOGY (2015)
A Rising Titan: TTN Review and Mutation Update
Claire Chauveau et al.
HUMAN MUTATION (2014)
Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment
Yu Zhang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases
Minoru Satoh et al.
Modern Rheumatology (2014)
Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer
Christine G. Joseph et al.
SCIENCE (2014)
Determinants of Mortality Among Postmenopausal Women in the Women's Health Initiative Who Report Rheumatoid Arthritis
Lewis H. Kuller et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Predictive Value of Autoantibody Testing for Validating Self-reported Diagnoses of Rheumatoid Arthritis in the Women's Health Initiative
Brian Walitt et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Serologic Autoantibodies as Diagnostic Cancer Biomarkers-A Review
Pauline Zaenker et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Autoantibody Signatures Involving Glycolysis and Splicesome Proteins Precede a Diagnosis of Breast Cancer among Postmenopausal Women
Jon J. Ladd et al.
CANCER RESEARCH (2013)
Natural IgG Autoantibodies Are Abundant and Ubiquitous in Human Sera, and Their Number Is Influenced By Age, Gender, and Disease
Eric P. Nagele et al.
PLOS ONE (2013)
Proteomic profiling of the autoimmune response to breast cancer antigens uncovers a suppressive effect of hormone therapy
Timothy Chao et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis
Sahra Borges et al.
BREAST CANCER RESEARCH (2013)
Prevalence and sociodemographic correlates of antinuclear antibodies in the United States
Minoru Satoh et al.
ARTHRITIS AND RHEUMATISM (2012)
Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study
Christopher I. Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Evaluation of Known Oncoantibodies, HER2, p53, and Cyclin B1, in Prediagnostic Breast Cancer Sera
Hailing Lu et al.
CANCER PREVENTION RESEARCH (2012)
Increased Plasma Levels of the APC-Interacting Protein MAPRE1, LRG1, and IGFBP2 Preceding a Diagnosis of Colorectal Cancer in Women
Jon J. Ladd et al.
CANCER PREVENTION RESEARCH (2012)
Concordant Release of Glycolysis Proteins into the Plasma Preceding a Diagnosis of ER+ Breast Cancer
Lynn M. Amon et al.
CANCER RESEARCH (2012)
Expression of the Stress Response Oncoprotein LEDGF/p75 in Human Cancer: A Study of 21 Tumor Types
Anamika Basu et al.
PLOS ONE (2012)
Protein Microarray Signature of Autoantibody Biomarkers for the Early Detection of Breast Cancer
Karen S. Anderson et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Emerging molecular biomarkers-blood-based strategies to detect and monitor cancer
Samir M. Hanash et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Definition of human autoimmunity - autoantibodies versus autoimmune disease
Ana Lleo et al.
AUTOIMMUNITY REVIEWS (2010)
Autoantibody profiles as biomarkers of breast cancer
Maria Dolores Tabernero et al.
CANCER BIOMARKERS (2010)
Serum autoantibodies as biomarkers for early cancer detection
Hwee Tong Tan et al.
FEBS JOURNAL (2009)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer
Hailing Lu et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman et al.
NATURE (2007)
Determination of ruthenium originating from the investigational anti-cancer drug NAMI-A in human plasma ultrafiltrate, plasma, and urine by inductively coupled plasma mass spectrometry
Elke E. M. Brouwers et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2007)
Anti-titin antibodies in myasthenia gravis -: Tight association with thymoma and heterogeneity of nonthymoma patients
AM Yamamoto et al.
ARCHIVES OF NEUROLOGY (2001)
分享论文
